2016 Innovation Grants - Prof. Helge Rasmussen

New therapeutic tools
Helge Rasmussen Panel Image

Prof. Helge Rasmussen

Grant

A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis 

Award

2016 Innovation Grant

Institution

University of Sydney

Pancreatic cancers have a very poor prognosis and the project team have discovered that a protein derivative sensitises cancer cells to currently used treatments, potentially making highly treatment-resistant pancreatic cancers responsive to chemotherapy and/or radiotherapy. The augmentation treatment effect by the derivative will be examined in human pancreatic cancers expressed in mice.

Helge Rasmussen Panel Image

Dr Helge Rasmussen, University of Sydney

Research Reports
Click to download progress reporting on the outcomes of this research.